Today on DrugResearcher.com
 
Big pharma's wish list

Invitrogen takes the stress out of stem cell 'passaging'

Drugs moving into the clinic: 24

Preclinical services news in brief

Pfizer offers insight on R&D outsourcing in Japan

 
   
Related Industry News
 
Sartorius Stedim profit decline masks growing biz

LifeCycle gets fenofibrate approval in US

Hikma makes inroads into Egyptian pharma market

Scottish firm targets South Korea for cancer patch

 
 

Drug discovery

Breaking News on Drug Discovery
Daily  Monday 13 August 2007 Forward to a colleague

Product Overview

STUARTInnovative New Shaking Incubator from Stuart®

A compact bench top incubator can be just enough for bacterial cell culturing. The latest shaking incubator from Stuart® is packed with novel features such as BioCote antimicrobial protection:... Click Here


Access Full Stories



Big pharma's wish list
Some of the world's largest pharma firms have set out what therapeutic areas and specific mechanisms are becoming more important to them, and which will be left by the wayside... Read


Invitrogen takes the stress out of stem cell 'passaging'
The launch of Invitrogen's Stempro EZPassage should substantially reduce the time and stress involved in dividing up cultures of human embryonic stem cell (hESC) colonies... Read


Drugs moving into the clinic: 24
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read


Preclinical services news in brief
In this week's review of activity within the preclinical research services arena, new deals have emerged involving GVK Biosciences, Lab Research, GATC Biotech and Bridge Pharmaceuticals... Read


Pfizer offers insight on R&D outsourcing in Japan
Pfizer, among others, recently offered an insight into R&D outsourcing in Japan, where this services market is still fairly immature, with growth potential in several key areas... Read


All News Headlines for:
August | July | June

DrugResearcherProduct Overview

A revolution in Sales Lead Generation! - Free Download

Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here
Related Industry News



Sartorius Stedim profit decline masks growing biz
Recently formed Sartorius Stedim Biotech has recorded rising sales and new business but a slight decrease in profit in the first half of the year, as it finalises its merger... Read


LifeCycle gets fenofibrate approval in US
The lowest formulated dose of cholesterol-busting fenofibrate has been approved for the US market using a new formulation platform... Read


Hikma makes inroads into Egyptian pharma market
UK Hikma Pharmaceuticals has acquired Egyptian pharmaceutical company Alkan Pharma in a deal worth $60.5m (€44.2m), and establishes the London-based company in the Egyptian market... Read


Scottish firm targets South Korea for cancer patch
Scottish company ProStrakan has landed a South Korean partner for its novel transdermal patch for chemotherapy-induced nausea, the firm's first patch product with ambitions to steal a sizeable chunk of a €2bn... Read

Outsourcing-Pharma.com special focus

Court sanctions independent trustee for Inyx USA

A US bankruptcy court judge ruled on Friday that Puerto Rican-based pharma services firm Inyx USA be put under the control of an independently-appointed trustee. Read



arrayjetProduct Literature

Advanced microarray printing for protein applications - Free Download

Arrayjet Ltd have developed a high quality, flexible and fast inkjet printing system and applied it to production of protein microarrays. Print proteomic and genomic microarrays with confidence using Arrayjet technology... Click Here

Previous Headlines



Charles River performs well in Q2
Charles River Laboratories posted healthy financial results for its second quarter, with both business units performing well... Read


Merck and Neuromed feel the pain
Merck & Co's latest bid to fill the gap left by the withdrawal of Vioxx (rofecoxib) has hit another stumbling block as it has dropped NMED-160 that it was developing in collaboration with Neuromed... Read


Jeol ups the ante with new 'entry level' NMR machine
Jeol has launched a new NMR (nuclear magnetic resonance) spectrometer that brings a high performance instrument to routine drug discovery and quality control applications, all in an 'entry level' package... Read


PerkinElmer reduces the cost of cellular imaging
PerkinElmer has launched an 'introductory configuration' of its Opera system to lower the upfront cost of adding high content screening (HCS) to drug discovery and systems biology programmes... Read


Nanoparticle tech to develop oral HIV vaccine
Emerging specialty pharmaceutical company Nanotherapeutics will be using its nanoparticle drug delivery technology to develop an HIV oral peptide vaccine after entering into a two year agreement with the National... Read

Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
La Tour du Triangle - 26, allee Jules Milhau - 34000 Montpellier - France
http://www.decisionnewsmedia.com